openPR Logo
Press release

Dr. David Sinclair Assumes Presidency of the Academy for Health and Lifespan Research

06-15-2023 02:09 PM CET | Health & Medicine

Press release from: Academy for Health and Lifespan Research

Dr. David Sinclair Assumes Presidency of the Academy for Health and Lifespan Research

Dr. David Sinclair Assumes Presidency of the Academy for Health and Lifespan Research

Dr. David Sinclair Assumes Presidency of the
Academy for Health and Lifespan Research
New York, June 14th, 2023 - The Academy for Health and Lifespan Research (AHLR) is proud
to announce the election of Dr. David Sinclair as its new President. Dr. Sinclair, a distinguished
Professor of Genetics at Harvard Medical School and renowned author of the New York Times
Bestseller "Lifespan," has been chosen by his peers to lead the prestigious association of the
world's foremost longevity researchers. He succeeds Dr. Felipe Sierra, Ph.D., in this role.
AHLR is the leading organization comprising the world's most esteemed scientists dedicated to
studying the mechanisms of aging and developing interventions to slow and reverse the process.
Its members are elected annually based on their significant scientific contributions and
commitment to the community.
The recent induction of 12 new members has expanded AHLR's membership to 60 scientists. As
a non-profit organization established in 2019, AHLR facilitates aging research, supports earlycareer scientists, offers public policy advice, and fosters collaboration among researchers. By
serving as a catalyst, idea pipeline, and convening body, the Academy empowers longevity
scientists to develop innovative drugs and treatments that can benefit all individuals.
The mission of AHLR encompasses several key objectives, including transforming societal
perceptions about healthy aging, promoting research for longer and healthier life, attracting talent
to the longevity research field, educating the public on science and healthy lifestyles, and
advocating for policy changes to recognize aging as a treatable condition. Previous meetings held
by the Academy in cities such as Paris, Lisbon, and Los Angeles have laid the groundwork for
these goals.
Dr. Sinclair expressed his gratitude for being elected as President, emphasizing the importance of
raising global awareness about aging research and the potential to improve the lives of millions
affected by age-related diseases like diabetes, dementia, and heart disease. He stated, "I am
excited to continue the mission of the Academy, tackling the root cause of age-related ailments,
which is aging itself."
Under Dr. Felipe Sierra's leadership, AHLR has experienced significant growth, with a
membership increase of over 25%. Additionally, the organization has secured funding, hired a
new Executive Director, and successfully organized a conference in Southern California,
attended by leading longevity scientists from around the world. Dr. Sierra will now focus on his
role at Hevolution, a non-profit dedicated to promoting aging research and rejuvenative
medicines globally, with an investment rate of approximately $1 billion a year.
Dr. Felipe Sierra expressed his pride in AHLR's achievements over the past year, including the
addition of 12 new members and the successful annual gathering. He expressed his confidence in
Dr. Sinclair, stating, "The Academy is a unique group of individuals at the forefront of medicine,
and we are thrilled to have Dr. Sinclair take over the helm."
Dr. Nir Barzilai, a renowned longevity researcher and founding board member of AHLR, added,
"The Academy is propelling the groundbreaking work conducted in laboratories worldwide. Dr.
Sinclair's leadership and his ability to engage with global leaders and the public make him an
ideal President."
The Academy believes that the question of whether it is possible to slow and reverse human
aging is at a crucial turning point in scientific exploration. With an increasing understanding of
the biology of aging and the malleability of the aging process, AHLR aims to harness the
collective power of accomplished longevity scientists to address the root causes of diseases
affecting billions worldwide.
For media inquiries and interview requests, please contact Risa Starr at risa@ahlresearch.org.
Follow AHLR and research on Twitter: @ahlresearch, @davidsinclair, @nirbarzilaiMD
Follow Dr. Sinclair on Instagram: @davidsinclairphd
About AHLR:
The Academy for Health and Lifespan Research (AHLR) is a non-profit organization founded in
2019, dedicated to advancing aging research, supporting scientists, advising on public policy, and
fostering collaboration. By uniting the world's leading scientists, laboratories, academic
institutions, and drug companies, AHLR strives to encourage breakthroughs in longevity
research that are accessible to all.
###
Note to editors:
High-resolution images and additional information about the Academy for Health and Lifespan
Research can be found at www.ahlresearch.org/press

The Academy for Health and Lifespan Research
215 West 104th
Box 1070
New York, N.Y. 10025

AHLR is the leading organization comprising the world's most esteemed scientists dedicated to
studying the mechanisms of aging and developing interventions to slow and reverse the process.
Its members are elected annually based on their significant scientific contributions and
commitment to the community.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dr. David Sinclair Assumes Presidency of the Academy for Health and Lifespan Research here

News-ID: 3089504 • Views: